FDA Drug recall D-0062-2025
ABSORBINE jr
- FDA Drug
- Class II
- terminated
- Published 2024-12-04
On 2024-12-04 the FDA classified a Class II recall of ABSORBINE jr by Unexo Life Sciences Private, citing cGMP Deviations.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0062-2025 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2024-10-24 |
| Published | 2024-12-04 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Unexo Life Sciences Private |
| Distribution | US |
Product
ABSORBINE jr. Extra Large BACK PATCH, Menthol 5%, 1 extra large patch per box, Distributed By: Absorbine Jr., LLC, Chattanooga, TN 37402 UPC 8 89476 41218 6, UPC 8 89476 41236 0
Reason
cGMP Deviations
Identifiers
| upc | 889476412186 |
|---|---|
| upc | 889476412360 |
| code_info | UPC 8 89476 41218 6, UPC 8 89476 41236 0 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0062-2025%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.